PubMed

Potential new cardiovascular risk factors: left ventricular hypertrophy, homocysteine, lipoprotein(a), triglycerides, oxidative stress, and fibrinogen.

Harjai KJ.

Ann Intern Med. 1999 Sep 7;131(5):376-86. Review.PMID: 10475891 [PubMed - indexed for MEDLINE]Related articlesFree article

Hyperhomocysteinemia, hyperfibrinogenemia, and lipoprotein (a) excess in maintenance dialysis patients: a matched case-control study.

Bostom AG, Shemin D, Lapane KL, Sutherland P, Nadeau MR, Wilson PW, Yoburn D, Bausserman L, Tofler G, Jacques PF, Selhub J, Rosenberg IH.

Atherosclerosis. 1996 Aug 23;125(1):91-101.PMID: 8831931 [PubMed - indexed for MEDLINE]Related articles

DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations.

Stanger O, Herrmann W, Pietrzik K, Fowler B, Geisel J, Dierkes J, Weger M; DACH-LIGA Homocystein e.V.

Clin Chem Lab Med. 2003 Nov;41(11):1392-403. Review. Erratum in: Clin Chem Lab Med. 2004 Jan;42(1):113-6. PMID: 14656016 [PubMed - indexed for MEDLINE]Related articles

The emerging risk factors for cardiovascular disease: a review of the epidemiologic evidence for lipoprotein(a), homocysteine, and fibrinogen.

Catena C, Cavarape A, Dotto L, Colussi G, Novehllo M, De Marchi S, Sechi LA.

Adv Clin Path. 2003 Jan;7(1):3-11. Review.PMID: 19774732 [PubMed - indexed for MEDLINE]Related articles

Coronary artery disease--free radical damage, antioxidant protection and the role of homocysteine.

Maxwell SR.

Basic Res Cardiol. 2000;95 Suppl 1:I65-71. Review.PMID: 11192356 [PubMed - indexed for MEDLINE]Related articles

Cardiovascular risk factors in predialysis patients: baseline data from the Chronic Renal Impairment in Birmingham (CRIB) study.

Wheeler DC, Townend JN, Landray MJ.

Kidney Int Suppl. 2003 May;(84):S201-3.PMID: 12694344 [PubMed - indexed for MEDLINE]Related articles

Evidence that triglycerides are an independent coronary heart disease risk factor.

Cullen P.

Am J Cardiol. 2000 Nov 1;86(9):943-9. Review.PMID: 11053704 [PubMed - indexed for MEDLINE]Related articles

Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence.

Hackam DG, Anand SS.

JAMA. 2003 Aug 20;290(7):932-40. Review.PMID: 12928471 [PubMed - indexed for MEDLINE]Related articlesFree article

Homocysteine and cardiovascular disease: current evidence and future prospects.

Mangoni AA, Jackson SH.

Am J Med. 2002 May;112(7):556-65. Review.PMID: 12015248 [PubMed - indexed for MEDLINE]Related articles

Hyperhomocysteinemia: an additional cardiovascular risk factor.

Fanapour PC, Yug B, Kochar MS.

WMJ. 1999 Dec;98(8):51-4. Review.PMID: 10639897 [PubMed - indexed for MEDLINE]Related articles

Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2.

de Luis DA, Fernandez N, Arranz ML, Aller R, Izaola O, Romero E.

J Diabetes Complications. 2005 Jan-Feb;19(1):42-6.PMID: 15642489 [PubMed - indexed for MEDLINE]Related articles

Vitamin E and heart disease: basic science to clinical intervention trials.

Pryor WA.

Free Radic Biol Med. 2000 Jan 1;28(1):141-64. Review.PMID: 10656300 [PubMed - indexed for MEDLINE]Related articles

Epidemiology of cardiovascular risk factors in chronic renal disease.

Coresh J, Longenecker JC, Miller ER 3rd, Young HJ, Klag MJ.

J Am Soc Nephrol. 1998 Dec;9(12 Suppl):S24-30. Review.PMID: 11443765 [PubMed - indexed for MEDLINE]Related articles

Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.

Nesto RW.

Am J Cardiovasc Drugs. 2005;5(6):379-87. Review.PMID: 16259526 [PubMed - indexed for MEDLINE]Related articles

New risk factors for atherosclerosis and patient risk assessment.

Fruchart JC, Nierman MC, Stroes ES, Kastelein JJ, Duriez P.

Circulation. 2004 Jun 15;109(23 Suppl 1):III15-9. Review.PMID: 15198961 [PubMed - indexed for MEDLINE]Related articlesFree article

Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin.

Breuer HW.

Curr Med Res Opin. 2001;17(1):60-73. Review.PMID: 11464448 [PubMed - indexed for MEDLINE]Related articles

Emerging cardiovascular risk factors that account for a significant portion of attributable mortality risk in chronic kidney disease.

Shishehbor MH, Oliveira LP, Lauer MS, Sprecher DL, Wolski K, Cho L, Hoogwerf BJ, Hazen SL.

Am J Cardiol. 2008 Jun 15;101(12):1741-6. Epub 2008 Apr 9.PMID: 18549850 [PubMed - indexed for MEDLINE]Related articles

Homocysteine, fibrinogen, and lipoprotein(a) levels are simultaneously reduced in patients with chronic renal failure treated with folic acid, pyridoxine, and cyanocobalamin.

Naruszewicz M, Klinke M, Dziewanowski K, Staniewicz A, Bukowska H.

Metabolism. 2001 Feb;50(2):131-4.PMID: 11229418 [PubMed - indexed for MEDLINE]Related articles

Hypertriglyceridemia: associated risks and effect of drug treatment.

Jonkers IJ, Smelt AH, van der Laarse A.

Am J Cardiovasc Drugs. 2001;1(6):455-66. Review.PMID: 14728004 [PubMed - indexed for MEDLINE]Related articles

Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease.

Ridker PM, Stampfer MJ, Rifai N.

JAMA. 2001 May 16;285(19):2481-5.PMID: 11368701 [PubMed - indexed for MEDLINE]Related articlesFree article